New Treatments and a Turning Point in Fatty Liver Disease Care with Dr. Meena Bansal

In this episode, Meena Bansal, MD, FAASLD - System Chief, Division of Liver Diseases Director, MASH/NASH Center of Excellence, Icahn School of Medicine at Mount Sinai, discusses newly approved therapies for MASH and the growing impact of GLP-1 medications. She also shares insights on personalized treatment, early intervention, and the future of liver disease care.